GUZMAN, A. Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S103-S104, 2018. DOI: 10.25251/skin.2.supp.98. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/447. Acesso em: 4 jul. 2024.